Holocene Advisors’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
Holocene Advisors's TEVA Position: Q3 2026 in Review
Holocene Advisors sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2026, closing a stake of 166,867 shares — an estimated $5.65M sold.
Holocene Advisors first reported a position in TEVA in Q3 2023 and held it in 10 quarters. The position peaked at $74.5M in Q2 2024. 600 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.
- Holocene Advisors reported no remaining Teva Pharmaceutical Industries position as of Q3 2026 after selling out during the quarter.
- Holocene Advisors sold 166,867 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $5.65M.
- Holocene Advisors first reported a position in Teva Pharmaceutical Industries in Q3 2023 and held it in 10 quarters.
- Holocene Advisors's Teva Pharmaceutical Industries position peaked at $74.5M in Q2 2024.
- 600 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.
Based on Holocene Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.